- Research works
- 96 ▼ 87% vs 2013–17
- Citations
- 2.7k 28.2 per fractional work
- Top-10% rate
- 7.8% record average 16.5%
- Open access
- 75% world 28%
Not ranked overall: Neovii Biotech (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.5×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.5×
- Veterinary 7.0×
- Immunology and Microbiology 2.8×
- Chemical Engineering 2.7×
- Chemistry 1.2×
- Medicine 1.2×
- Engineering 1.1×
- Physics and Astronomy 0.9×
- Agricultural and Biological Sciences 0.8×
- Materials Science 0.6×
- Computer Science 0.5×
- Nursing 0.3×
- Neuroscience 0.3×
- Environmental Science 0.3×
- Health Professions 0.1×
Which keywords describe research at Neovii Biotech (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Biosensors, Cancer Immunotherapy and Gene Therapy.
- Tumor Antigen
- Dendritic Cells
- Recombinant Protein
- Cytoreductive Surgery
- Protein Microarrays
- High-Throughput Analysis
- Biopharmaceuticals
- Regeneration
- Lab-on-a-Chip
- Graft Survival
- Differentiation
- Cancer Therapy
- Tumor Regression
- Cell Culture
- Chemotherapy
- Gene Therapy
- Immunotherapy
- Inflammation
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Biosensors
- Cancer Immunotherapy
- Cancer
- Gene Expression
- Targeted Therapy
- Biopharmaceutical Production
- Microfluidic Devices
- Immunity
- Monoclonal Antibody
- PET Imaging
- Transplantation
- Genomic Integration
- Point-of-Care Diagnostics
- Transcriptional Regulation
- Mammalian Cells
- Antigen Presentation
- Regenerative Medicine
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation9▲ 40×3 topics
- Monoclonal Antibodies6▲ 40×3 topics
- Therapeutic Antibodies5▲ 43×2 topics
- Antibody Engineering5▲ 53×1 topic
- Fc Receptors5▲ 53×1 topic
- Inflammation5▲ 2.1×20 topics
- Biosensors4▲ 7.7×5 topics
- Immunotherapy4▲ 6.6×7 topics
- Cancer Immunotherapy4▲ 30×2 topics
- Gene Therapy4▲ 15×4 topics
- Cancer4▲ 2.7×14 topics
- Chemotherapy4▲ 5.0×10 topics
- Gene Expression4▲ 6.0×8 topics
- Cell Culture3▲ 31×2 topics
- Targeted Therapy3▲ 15×5 topics
- Tumor Regression3▲ 38×2 topics
- Biopharmaceutical Production3▲ 40×2 topics
- Cancer Therapy3▲ 4.8×11 topics
- Microfluidic Devices3▲ 37×2 topics
- Differentiation3▲ 40×2 topics
- Immunity3▲ 8.2×4 topics
- Graft Survival3▲ 26×3 topics
- Monoclonal Antibody3▲ 38×2 topics
- Lab-on-a-Chip2▲ 18×3 topics
- PET Imaging2▲ 12×4 topics
- Regeneration2▲ 14×3 topics
- Transplantation2▲ 22×3 topics
- Biopharmaceuticals2▲ 36×3 topics
- Genomic Integration2▲ 24×2 topics
- High-Throughput Analysis2▲ 55×1 topic
- Point-of-Care Diagnostics2▲ 29×2 topics
- Protein Microarrays2▲ 127×1 topic
- Transcriptional Regulation2▲ 10×6 topics
- Cytoreductive Surgery2▲ 37×2 topics
- Mammalian Cells2▲ 61×1 topic
- Recombinant Protein2▲ 61×1 topic
- Antigen Presentation2▲ 23×2 topics
- Dendritic Cells2▲ 19×1 topic
- Regenerative Medicine2▲ 10×4 topics
- Tumor Antigen2▲ 28×1 topic
Which research topics does Neovii Biotech (Germany) publish most on?
By volume in 2022–2025: Biosensors and Analytical Detection, Advanced Biosensing Techniques and Applications, Advanced biosensing and bioanalysis techniques and Hair Growth and Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Biosensors and Analytical Detection Biomedical Engineering 2 works
- 2 Advanced Biosensing Techniques and Applications Molecular Biology 2 works
- 3 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
- 4 Hair Growth and Disorders Urology 1 works
- 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 6 Animal Genetics and Reproduction Genetics 0 works
- 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 8 Plant tissue culture and regeneration Molecular Biology 0 works
- 9 Machine Learning in Bioinformatics Molecular Biology 0 works
- 10 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Neovii Biotech (Germany)'s research output changed?
Output in 2018–2022 was 87% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Gräfelfing
- International Medical Research (Germany)
- Toptica Photonics (Germany)
- Forschungsinstitut für Wärmeschutz München
- PharmaFGP (Germany)
- Naturland
- Dr. Hönle (Germany)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.